taurine has been researched along with Chronic Disease in 43 studies
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effect of oral taurine supplementation on frequency, duration, and intensity of muscle cramps in patients with chronic liver disease." | 9.27 | Randomised clinical trial: oral taurine supplementation versus placebo reduces muscle cramps in patients with chronic liver disease. ( Allman-Farinelli, M; Carey, S; Cvejic, E; McCaughan, GW; Shackel, NA; Strasser, SI; Vidot, H, 2018) |
| "We compared the effect of oral administration of taurine (3 g/day) and coenzyme Q10 (CoQ10) (30 mg/day) in 17 patients with congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy, whose ejection fraction assessed by echocardiography was less than 50%." | 9.07 | Usefulness of taurine in chronic congestive heart failure and its prospective application. ( Awata, N; Azuma, J; Sawamura, A, 1992) |
| "Latrunculin A microperfusion of the hippocampus induces acute epileptic seizures and long-term biochemical changes leading to spontaneous seizures." | 7.80 | Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus. ( Loureiro, AI; Sierra-Marcuño, G; Sierra-Paredes, G; Soares-da-Silva, P; Wright, LC, 2014) |
| "This study was designed to characterize, in anterior, mediobasal, and posterior hypothalamic and median eminence, the 24h changes of gamma aminobutyric acid (GABA) and taurine (TAU) contents in adult male rats and to analyze whether chronic hyperprolactinemia may affect these patterns." | 7.72 | Daily changes of GABA and taurine concentrations in various hypothalamic areas are affected by chronic hyperprolactinemia. ( Alvarez, MP; Cano, P; Castrillón, PO; Duvilanski, BH; Esquifino, AI, 2003) |
| "It was recently demonstrated that renal failure and exogenous urea prevent myelinolysis induced by rapid correction of experimental hyponatremia." | 7.71 | Rapid (24-hour) reaccumulation of brain organic osmolytes (particularly myo-inositol) in azotemic rats after correction of chronic hyponatremia. ( Decaux, G; Schroöeder, B; Silver, S; Soupart, A; Sterns, R, 2002) |
| "The therapeutic effects of 2-aminoethanesulfonic acid (taurine) were tested in animals with congestive heart failure (HF) simulated by aortic valve damage." | 7.68 | [Use of taurine in the treatment of experimental congestive heart failure]. ( Elizarova, EP; Fetisova, NI; Mit'kina, LI; Orlova, TsR; Ryff, IM, 1991) |
| "We have previously shown that in the cat, taurine is an osmoprotective molecule that lessens mortality, neurological morbidity, and brain-cell dehydration during chronic hypernatremic dehydration." | 7.67 | Taurine and osmoregulation. II. Administration of taurine analogues affords cerebral osmoprotection during chronic hypernatremic dehydration. ( Del Pizzo, R; Finberg, L; Huxtable, RJ; Sturman, JA; Trachtman, H, 1988) |
| "We studied the effect of 8-wk dietary taurine depletion on the vulnerability to hypernatremic dehydration in postweanling kittens." | 7.67 | Taurine and osmoregulation: taurine is a cerebral osmoprotective molecule in chronic hypernatremic dehydration. ( Barbour, R; Finberg, L; Sturman, JA; Trachtman, H, 1988) |
| "To examine the effect of daily treatment with taurine on improving the status of congestive heart failure (CHF), we used rabbits with artificially induced aortic regurgitation." | 7.67 | Beneficial effect of taurine in rabbits with chronic congestive heart failure. ( Awata, N; Azuma, J; Hamaguchi, T; Kishimoto, S; Ohta, H; Sawamura, A; Sperelakis, N; Takihara, K; Tanaka, Y, 1986) |
| "Taurine has also attracted attention because it has beneficial actions in CHF, in part by its demonstrated inhibition of the harmful actions of the neurohumoral factors." | 6.50 | The effect of taurine on chronic heart failure: actions of taurine against catecholamine and angiotensin II. ( Azuma, J; Ito, T; Schaffer, S, 2014) |
| "Taurine was effective for CHF patients on HDF in whom dry weight was difficult to control in spite of various medications." | 5.43 | Effect of Taurine on Hemodiafiltration in Patients With Chronic Heart Failure. ( Kawaguchi, H; Komatsu, M; Naganuma, T; Nitta, K; Okazaki, M; Shiohira, S; Tsuchiya, K, 2016) |
| "To investigate the effect of oral taurine supplementation on frequency, duration, and intensity of muscle cramps in patients with chronic liver disease." | 5.27 | Randomised clinical trial: oral taurine supplementation versus placebo reduces muscle cramps in patients with chronic liver disease. ( Allman-Farinelli, M; Carey, S; Cvejic, E; McCaughan, GW; Shackel, NA; Strasser, SI; Vidot, H, 2018) |
| "We compared the effect of oral administration of taurine (3 g/day) and coenzyme Q10 (CoQ10) (30 mg/day) in 17 patients with congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy, whose ejection fraction assessed by echocardiography was less than 50%." | 5.07 | Usefulness of taurine in chronic congestive heart failure and its prospective application. ( Awata, N; Azuma, J; Sawamura, A, 1992) |
| "Latrunculin A microperfusion of the hippocampus induces acute epileptic seizures and long-term biochemical changes leading to spontaneous seizures." | 3.80 | Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus. ( Loureiro, AI; Sierra-Marcuño, G; Sierra-Paredes, G; Soares-da-Silva, P; Wright, LC, 2014) |
| "This study was designed to characterize, in anterior, mediobasal, and posterior hypothalamic and median eminence, the 24h changes of gamma aminobutyric acid (GABA) and taurine (TAU) contents in adult male rats and to analyze whether chronic hyperprolactinemia may affect these patterns." | 3.72 | Daily changes of GABA and taurine concentrations in various hypothalamic areas are affected by chronic hyperprolactinemia. ( Alvarez, MP; Cano, P; Castrillón, PO; Duvilanski, BH; Esquifino, AI, 2003) |
| "It was recently demonstrated that renal failure and exogenous urea prevent myelinolysis induced by rapid correction of experimental hyponatremia." | 3.71 | Rapid (24-hour) reaccumulation of brain organic osmolytes (particularly myo-inositol) in azotemic rats after correction of chronic hyponatremia. ( Decaux, G; Schroöeder, B; Silver, S; Soupart, A; Sterns, R, 2002) |
| "The therapeutic effects of 2-aminoethanesulfonic acid (taurine) were tested in animals with congestive heart failure (HF) simulated by aortic valve damage." | 3.68 | [Use of taurine in the treatment of experimental congestive heart failure]. ( Elizarova, EP; Fetisova, NI; Mit'kina, LI; Orlova, TsR; Ryff, IM, 1991) |
| "We have previously shown that in the cat, taurine is an osmoprotective molecule that lessens mortality, neurological morbidity, and brain-cell dehydration during chronic hypernatremic dehydration." | 3.67 | Taurine and osmoregulation. II. Administration of taurine analogues affords cerebral osmoprotection during chronic hypernatremic dehydration. ( Del Pizzo, R; Finberg, L; Huxtable, RJ; Sturman, JA; Trachtman, H, 1988) |
| "We studied the effect of 8-wk dietary taurine depletion on the vulnerability to hypernatremic dehydration in postweanling kittens." | 3.67 | Taurine and osmoregulation: taurine is a cerebral osmoprotective molecule in chronic hypernatremic dehydration. ( Barbour, R; Finberg, L; Sturman, JA; Trachtman, H, 1988) |
| "To examine the effect of daily treatment with taurine on improving the status of congestive heart failure (CHF), we used rabbits with artificially induced aortic regurgitation." | 3.67 | Beneficial effect of taurine in rabbits with chronic congestive heart failure. ( Awata, N; Azuma, J; Hamaguchi, T; Kishimoto, S; Ohta, H; Sawamura, A; Sperelakis, N; Takihara, K; Tanaka, Y, 1986) |
| "Taurine has also attracted attention because it has beneficial actions in CHF, in part by its demonstrated inhibition of the harmful actions of the neurohumoral factors." | 2.50 | The effect of taurine on chronic heart failure: actions of taurine against catecholamine and angiotensin II. ( Azuma, J; Ito, T; Schaffer, S, 2014) |
| "Taurine was effective for CHF patients on HDF in whom dry weight was difficult to control in spite of various medications." | 1.43 | Effect of Taurine on Hemodiafiltration in Patients With Chronic Heart Failure. ( Kawaguchi, H; Komatsu, M; Naganuma, T; Nitta, K; Okazaki, M; Shiohira, S; Tsuchiya, K, 2016) |
| "Taurine is a structurally simple amino acid, and has been reported to have several putative roles, such as neurotransmitter, neuromodulator, neurogrowth factor and to function in membrane stabilization." | 1.28 | [Immunohistochemical study of the human olfactory system]. ( Ashihara, M; Nagatsu, I; Nishimura, T; Sakai, M; Takuya, O, 1992) |
| "Taurine-treated nephrotic rats had a reduction in albuminuria, as assessed by the urinary albumin-to-creatinine ratio (26 +/- 4 vs." | 1.28 | Taurine attenuates renal disease in chronic puromycin aminonucleoside nephropathy. ( Del Pizzo, R; Futterweit, S; Levine, D; Rao, PS; Sturman, JA; Trachtman, H; Valderrama, E, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (30.23) | 18.7374 |
| 1990's | 10 (23.26) | 18.2507 |
| 2000's | 9 (20.93) | 29.6817 |
| 2010's | 10 (23.26) | 24.3611 |
| 2020's | 1 (2.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T | 1 |
| Zhou, K | 1 |
| Sun, T | 1 |
| Sang, C | 1 |
| Jia, W | 1 |
| Xie, G | 1 |
| Vidot, H | 1 |
| Cvejic, E | 1 |
| Carey, S | 1 |
| Strasser, SI | 1 |
| McCaughan, GW | 1 |
| Allman-Farinelli, M | 1 |
| Shackel, NA | 1 |
| Kyriakopoulos, AM | 1 |
| Grapsa, E | 1 |
| Marcinkiewicz, J | 1 |
| Nagl, M | 3 |
| Ito, T | 1 |
| Schaffer, S | 1 |
| Azuma, J | 3 |
| Kim, C | 1 |
| Cha, YN | 1 |
| Hsieh, YL | 1 |
| Yeh, YH | 1 |
| Lee, YT | 1 |
| Huang, CY | 1 |
| Sierra-Paredes, G | 1 |
| Loureiro, AI | 1 |
| Wright, LC | 1 |
| Sierra-Marcuño, G | 1 |
| Soares-da-Silva, P | 1 |
| Oleynikova, ON | 1 |
| Makarova, LM | 1 |
| Pogoreliy, VE | 1 |
| Novikova, NA | 1 |
| Averin, E | 1 |
| Shiohira, S | 1 |
| Komatsu, M | 1 |
| Okazaki, M | 1 |
| Naganuma, T | 1 |
| Kawaguchi, H | 1 |
| Nitta, K | 1 |
| Tsuchiya, K | 1 |
| Shearer, J | 1 |
| Graham, TE | 1 |
| Skinner, TL | 1 |
| Duarte, JM | 1 |
| Carvalho, RA | 1 |
| Cunha, RA | 1 |
| Gruetter, R | 1 |
| Duvilanski, BH | 1 |
| Alvarez, MP | 1 |
| Castrillón, PO | 1 |
| Cano, P | 1 |
| Esquifino, AI | 1 |
| O'Brien, CP | 1 |
| TURNER, FP | 1 |
| BRUM, VC | 1 |
| PAQUETTE, WW | 1 |
| WELDEN, RB | 1 |
| Nguyen, VA | 1 |
| Gottardi, W | 1 |
| Ulmer, H | 2 |
| Höpfl, R | 1 |
| Neher, A | 1 |
| Fischer, H | 1 |
| Appenroth, E | 1 |
| Lass-Flörl, C | 1 |
| Mayr, A | 1 |
| Gschwendtner, A | 1 |
| Gotwald, TF | 1 |
| Gstöttner, M | 1 |
| Kozlov, V | 1 |
| Schneider, SM | 1 |
| Joly, F | 1 |
| Gehrardt, MF | 1 |
| Badran, AM | 1 |
| Myara, A | 1 |
| Thuillier, F | 1 |
| Coudray-Lucas, C | 1 |
| Cynober, L | 1 |
| Trivin, F | 1 |
| Messing, B | 1 |
| Burri, C | 2 |
| Trachtman, H | 4 |
| Futterweit, S | 2 |
| Maesaka, J | 1 |
| Ma, C | 1 |
| Valderrama, E | 2 |
| Fuchs, A | 1 |
| Tarectecan, AA | 1 |
| Rao, PS | 2 |
| Sturman, JA | 4 |
| Boles, TH | 1 |
| Dudariev, VP | 1 |
| Lanovenko, II | 1 |
| Spanagel, R | 1 |
| Kornhuber, J | 1 |
| Bitoun, M | 1 |
| Tappaz, M | 1 |
| Ward, RJ | 1 |
| Martinez, J | 1 |
| Ball, D | 1 |
| Marshall, EJ | 1 |
| De Witte, P | 1 |
| Soupart, A | 1 |
| Silver, S | 1 |
| Schroöeder, B | 1 |
| Sterns, R | 1 |
| Decaux, G | 1 |
| Ikeda, H | 1 |
| Ashihara, M | 1 |
| Takuya, O | 1 |
| Nishimura, T | 1 |
| Sakai, M | 1 |
| Nagatsu, I | 1 |
| Zawadziński, S | 1 |
| Benke, G | 1 |
| Eluszkiewicz, S | 1 |
| Wasikowski, A | 1 |
| Zarek, S | 1 |
| Sawamura, A | 2 |
| Awata, N | 2 |
| Del Pizzo, R | 2 |
| Levine, D | 1 |
| Orlova, TsR | 1 |
| Elizarova, EP | 1 |
| Ryff, IM | 1 |
| Fetisova, NI | 1 |
| Mit'kina, LI | 1 |
| Moen, BE | 1 |
| Kyvik, KR | 1 |
| Engelsen, BA | 1 |
| Riise, T | 1 |
| Korpi, ER | 1 |
| Kaufmann, CA | 1 |
| Marnela, KM | 1 |
| Weinberger, DR | 1 |
| Huxtable, RJ | 1 |
| Finberg, L | 2 |
| Barbour, R | 1 |
| Takihara, K | 1 |
| Ohta, H | 1 |
| Hamaguchi, T | 1 |
| Tanaka, Y | 1 |
| Kishimoto, S | 1 |
| Sperelakis, N | 1 |
| Mårtensson, J | 1 |
| Bolin, T | 1 |
| Mutani, R | 1 |
| Bergamini, L | 1 |
| Delsedime, M | 1 |
| Durelli, L | 1 |
| Smagin, VG | 1 |
| Asafov, GB | 1 |
| Ekisenina, NI | 1 |
| Ivanova, LM | 1 |
| Lumel'skiĭ, VIa | 1 |
| Szantay, I | 1 |
| Popescu, TA | 1 |
| Cucuianu, M | 1 |
| Mestyán, J | 1 |
| Fekete, M | 1 |
| Soltész, G | 1 |
| Járai, I | 1 |
| Gáti, I | 1 |
| Preisz, J | 1 |
| Doszpod, J | 1 |
| Ostrow, JD | 1 |
5 reviews available for taurine and Chronic Disease
| Article | Year |
|---|---|
The effect of taurine on chronic heart failure: actions of taurine against catecholamine and angiotensin II.
Topics: Angiotensin II; Animals; Catecholamines; Chronic Disease; Heart Failure; Humans; Renin-Angiotensin S | 2014 |
Taurine chloramine produced from taurine under inflammation provides anti-inflammatory and cytoprotective effects.
Topics: Animals; Antioxidants; Apoptosis; Chronic Disease; Cytoprotection; Humans; Inflammation; Inflammatio | 2014 |
Nutra-ergonomics: influence of nutrition on physical employment standards and the health of workers.
Topics: Amino Acids; Beverages; Caffeine; Chronic Disease; Diet, Healthy; Dietary Proteins; Employment; Ergo | 2016 |
Research advances in the understanding and treatment of addiction.
Topics: Acamprosate; Alcohol Deterrents; Brain; Chronic Disease; Disease Progression; Humans; Naltrexone; Na | 2003 |
[Treatment of local infection with taurolin].
Topics: Anti-Infective Agents, Local; Bacterial Infections; Chronic Disease; Fracture Fixation, Internal; Ge | 1990 |
6 trials available for taurine and Chronic Disease
| Article | Year |
|---|---|
Randomised clinical trial: oral taurine supplementation versus placebo reduces muscle cramps in patients with chronic liver disease.
Topics: Administration, Oral; Australia; Chronic Disease; Dietary Supplements; Female; Humans; Liver Disease | 2018 |
Use of taurine during rehabilitation after cardiac surgery.
Topics: Adult; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Chronic Disease; Female; Heart Failure; | 2015 |
Tolerability and efficacy of N-chlorotaurine in comparison with chloramine T for the treatment of chronic leg ulcers with a purulent coating: a randomized phase II study.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Local; Chloramines; | 2003 |
Tolerability of N-chlorotaurine in chronic rhinosinusitis applied via yamik catheter.
Topics: Adult; Anti-Infective Agents; Catheterization; Chronic Disease; Female; Humans; Male; Middle Aged; S | 2005 |
Taurine status and response to intravenous taurine supplementation in adults with short-bowel syndrome undergoing long-term parenteral nutrition: a pilot study.
Topics: Adult; Amino Acids; Bile Acids and Salts; Cholestasis, Intrahepatic; Chronic Disease; Epidemiologic | 2006 |
Usefulness of taurine in chronic congestive heart failure and its prospective application.
Topics: Administration, Oral; Cardiomyopathy, Dilated; Chronic Disease; Coenzymes; Coronary Disease; Double- | 1992 |
32 other studies available for taurine and Chronic Disease
| Article | Year |
|---|---|
Altered bile acid glycine : taurine ratio in the progression of chronic liver disease.
Topics: Bile Acids and Salts; Case-Control Studies; Chronic Disease; Disease Progression; Female; Glycine; H | 2022 |
Swift Cure of a Chronic Wound Infected With Multiresistant
Topics: Administration, Topical; Aged, 80 and over; Anti-Infective Agents; Anti-Inflammatory Agents; Chronic | 2019 |
Effect of taurine in chronic alcoholic patients.
Topics: Aged; Alanine Transaminase; Alcohol Dehydrogenase; Alcoholism; Aldehyde Dehydrogenase; Antioxidants; | 2014 |
Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus.
Topics: Acute Disease; Amino Acids; Animals; Anticonvulsants; Aspartic Acid; Bridged Bicyclo Compounds, Hete | 2014 |
Experimental study of taurine antitoxic activity in the model of chronic epinephrine intoxication.
Topics: Animals; Animals, Outbred Strains; Arteries; Calcium; Cerebrum; Chronic Disease; Cytoprotection; Dis | 2015 |
Effect of Taurine on Hemodiafiltration in Patients With Chronic Heart Failure.
Topics: Aged; Aged, 80 and over; Cardiovascular Agents; Chronic Disease; Drug Monitoring; Echocardiography; | 2016 |
Caffeine consumption attenuates neurochemical modifications in the hippocampus of streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Caffeine; Central Nervous System Stimulants; Chronic Disease; Diabetes Melli | 2009 |
Daily changes of GABA and taurine concentrations in various hypothalamic areas are affected by chronic hyperprolactinemia.
Topics: Animals; Chronic Disease; Circadian Rhythm; gamma-Aminobutyric Acid; Hyperprolactinemia; Hypothalamu | 2003 |
THE URINARY EXCRETION OF FREE TAURINE IN ACUTE AND CHRONIC DISEASE, FOLLOWING SURGICAL TRAUMA, AND IN PATIENTS WITH ACUTE ALCOHOLISM.
Topics: Adrenal Cortex Hormones; Alcoholism; Biliary Tract; Biomedical Research; Cholecystitis; Cholelithias | 1964 |
[Chronic osteitis of the lower leg].
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Chronic Disease; Combined Modality Therapy; Fra | 1984 |
Taurine ameliorates chronic streptozocin-induced diabetic nephropathy in rats.
Topics: Animals; Chronic Disease; Collagen; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glycati | 1995 |
[Changes in the oxygen-binding properties of the blood in white rats under the influence of hypoxia and its pharmacological correction].
Topics: Acute Disease; Animals; Antioxidants; Butylated Hydroxytoluene; Chronic Disease; Drug Evaluation, Pr | 1999 |
[Glutamate receptor agonists and alcohol dependence. Preclinical findings].
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Chronic Disease; Disease Models, Animal; Human | 1999 |
Gene expression of taurine transporter and taurine biosynthetic enzymes in brain of rats with acute or chronic hyperosmotic plasma. A comparative study with gene expression of myo-inositol transporter, betaine transporter and sorbitol biosynthetic enzyme.
Topics: Acute Disease; Aldehyde Reductase; Animals; Brain; Carboxy-Lyases; Carrier Proteins; Chronic Disease | 2000 |
Investigation of the therapeutic efficacy of a taurine analogue during the initial stages of ethanol detoxification: preliminary studies in chronic alcohol abusers.
Topics: Acamprosate; Alcoholism; Amino Acids; Chlordiazepoxide; Chronic Disease; Ethanol; GABA Modulators; G | 2000 |
Rapid (24-hour) reaccumulation of brain organic osmolytes (particularly myo-inositol) in azotemic rats after correction of chronic hyponatremia.
Topics: Animals; Body Water; Brain; Chronic Disease; Hyponatremia; Inositol; Male; Mercuric Chloride; Potass | 2002 |
Effects of taurine on alcohol withdrawal.
Topics: Alcoholism; Chronic Disease; Ethanol; Humans; Substance Withdrawal Syndrome; Taurine | 1977 |
[Immunohistochemical study of the human olfactory system].
Topics: Adolescent; Adult; Carnosine; Chronic Disease; Epithelium; Female; Humans; Immunohistochemistry; Inf | 1992 |
["Taurolin-Gel" and Taurolin-Trockengel" in treatment of osseous tissue inflammation].
Topics: Anti-Infective Agents, Local; Chronic Disease; Gels; Humans; Osteitis; Recurrence; Taurine; Thiadiaz | 1990 |
Taurine attenuates renal disease in chronic puromycin aminonucleoside nephropathy.
Topics: Animals; Chronic Disease; Creatinine; Kidney; Kidney Diseases; Male; Proteinuria; Puromycin Aminonuc | 1992 |
[Use of taurine in the treatment of experimental congestive heart failure].
Topics: Animals; Chronic Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Heart Failure; Hemod | 1991 |
Cerebrospinal fluid proteins and free amino acids in patients with solvent induced chronic toxic encephalopathy and healthy controls.
Topics: Aged; Albumins; Amino Acids; Brain Diseases; Cerebrospinal Fluid Proteins; Chronic Disease; Humans; | 1990 |
Cerebrospinal fluid amino acid concentrations in chronic schizophrenia.
Topics: Adult; Aged; Alanine; Amino Acids; Chronic Disease; Female; Glutamates; Glutamic Acid; Glutamine; Gl | 1987 |
Taurine and osmoregulation. II. Administration of taurine analogues affords cerebral osmoprotection during chronic hypernatremic dehydration.
Topics: Animals; Body Water; Brain; Chronic Disease; Dehydration; Hypernatremia; Muscles; Phthalimides; Rats | 1988 |
Taurine and osmoregulation: taurine is a cerebral osmoprotective molecule in chronic hypernatremic dehydration.
Topics: Animals; Body Water; Brain; Cats; Chronic Disease; Dehydration; Hypernatremia; Muscles; Potassium; S | 1988 |
Beneficial effect of taurine in rabbits with chronic congestive heart failure.
Topics: Animals; Aortic Valve Insufficiency; Calcium; Chronic Disease; Drug Evaluation, Preclinical; Heart F | 1986 |
Sulfur amino acid metabolism in chronic relapsing pancreatitis.
Topics: Adult; Aged; Alcoholism; Amino Acids, Sulfur; Cholecystectomy; Chronic Disease; Cystathionine; Cyste | 1986 |
Effects of taurine in chronic experimental epilepsy.
Topics: Aluminum Hydroxide; Animals; Anticonvulsants; Cats; Chronic Disease; Seizures; Taurine; Time Factors | 1974 |
[Amino acid levels in the blood serum of patients with chronic colitis].
Topics: Adult; Alanine; Amino Acids; Ammonia; Arginine; Aspartic Acid; Betaine; Chronic Disease; Citrulline; | 1974 |
Some aspects of the metabolism of (35S) methionine in hyperlipemic subjects.
Topics: Chromatography; Chronic Disease; Hepatitis; Humans; Hyperlipidemias; Injections, Intravenous; Methio | 1971 |
The postnatal changes in the circulating free amino acid pool in the newborn infant. 3. The plasma amino acid ratio in infants born after pregnancies complicated by toxaemia, placental infarction, impaired umbilical circulation and chronic maternal diseas
Topics: Amino Acids; Chronic Disease; Female; Glutamine; Glycine; Heart Defects, Congenital; Heart Failure; | 1971 |
Absorption of organic compounds by the injured gallbladder.
Topics: Acute Disease; Animals; Bile Acids and Salts; Bilirubin; Carbon Isotopes; Cholecystitis; Cholelithia | 1971 |